|

Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis

RECRUITINGSponsored by University of Salerno
Actively Recruiting
SponsorUniversity of Salerno
Started2024-03-01
Est. completion2025-03-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06589063

Summary

LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular: * risk factors * gender differences * comorbidities * pharmacological treatment * TAVR procedural characteristics * periprocedural and in-hospital complications * clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* LFLG-AS diagnosis according to current European Society of Cardiology guidelines
* Age 18 years or older
* Written informed consent

Exclusion Criteria:

* LFLG-AS pseudo-severe or non-confirmed severe aortic stenosis
* LFLG-AS referred for medical treatment or undergoing surgery

Conditions2

Heart DiseaseLow Flow, Low Gradient Aortic Stenosis

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.